Drug Profile
Shigella flexneri vaccine CVD 1205
Latest Information Update: 31 Aug 1998
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Shigella infections
Most Recent Events
- 31 Aug 1998 No-Development-Reported for Shigella infections in USA (Unknown route)
- 01 Nov 1996 New profile
- 01 Nov 1996 Preclinical development for Shigella infections in USA (Unknown route)